clindamycin and Hematologic Malignancies

clindamycin has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cordonnier, C; Helweg-Larsen, J; Maschmeyer, G; Pagano, L; Robin, C; Schellongowski, P1

Other Studies

1 other study(ies) available for clindamycin and Hematologic Malignancies

ArticleYear
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9

    Topics: Administration, Intravenous; Antifungal Agents; Clindamycin; Hematologic Neoplasms; Humans; Pneumocystis carinii; Pneumonia, Pneumocystis; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination

2016